IP Verse

Antisense Nucleic Acids - EP3018211

The patent EP3018211 was granted to National Center OF Neurology And Psychiatry on Aug 7, 2019. The application was originally filed on Aug 31, 2011 under application number EP15199455A. The patent is currently recorded with a legal status of "Revoked".

EP3018211

NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
Application Number
EP15199455A
Filing Date
Aug 31, 2011
Status
Revoked
May 13, 2022
Grant Date
Aug 7, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMay 7, 2020CARPMAELS & RANSFORDADMISSIBLE
SAREPTA THERAPEUTICSMay 6, 2020D YOUNGADMISSIBLE

Patent Citations (22) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONJP2006038608
DESCRIPTIONJP2006129594
DESCRIPTIONJP2008096690
DESCRIPTIONJP2924179B
DESCRIPTIONUS2010168212
DESCRIPTIONWO2004048570
DESCRIPTIONWO2006000057
DESCRIPTIONWO2009064471
DESCRIPTIONWO2010048586
DESCRIPTIONWO9109033
OPPOSITIONEP2612917
OPPOSITIONUS2007082861
OPPOSITIONUS2010130591
OPPOSITIONUS2010168212
OPPOSITIONUS6784291
OPPOSITIONWO2004083432
OPPOSITIONWO2006000057
OPPOSITIONWO2010048586
OPPOSITIONWO2011057350
OPPOSITIONWO2014153240
SEARCHUS2010168212
SEARCHWO2010048586

Non-Patent Literature (NPL) Citations (24) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALTSCHUL SF ET AL., J. MOL. BIOL., (1990), vol. 215, page 403
DESCRIPTION- ALUL ET AL., NUCLEIC ACIDS RESEARCH, (1991), vol. 19, page 1527
DESCRIPTION- ANNEMIEKE AARTSMA-RUS ET AL., NEUROMUSCULAR DISORDERS, (2002), vol. 12, pages S71 - S77
DESCRIPTION- ENYA ET AL., BIOORGANIC & MEDICINAL CHEMISTRY, (2008), vol. 18, pages 9154 - 9160
DESCRIPTION- KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, (1990), pages 872264 - 872268
DESCRIPTION- K. L. DUEHOLM; M. EGHOLM; C. BEHRENS; L. CHRISTENSEN; H. F. HANSEN; T. VULPIUS; K. H. PETERSEN; R. H. BERG; P. E. NIELSEN; O. BUCH, J. ORG. CHEM., (1994), vol. 59, page 5767
DESCRIPTION- L. CHRISTENSEN; R. FITZPATRICK; B. GILDEA; K. H. PETERSEN; H. F. HANSEN; T. KOCH; M. EGHOLM; O. BUCHARDT; P. E. NIELSEN; J. COULL, J. PEPT. SCI., (1995), vol. 1, page 175
DESCRIPTION- LINDA J. POPPLEWELL ET AL., NEUROMUSCULAR DISORDERS, (2010), vol. 20, no. 2, pages 102 - 110
DESCRIPTION- MATSUO M., BRAIN DEV, (1996), vol. 18, pages 167 - 172
DESCRIPTION- M. EGHOLM; O. BUCHARDT; P. E. NIELSEN; R. H. BERG, JACS, (1992), vol. 114, page 1895
DESCRIPTION- MONACO A. P. ET AL., GENOMICS, (1988), vol. 2, pages 90 - 95
DESCRIPTION- ORG. LETT., (2004), vol. 6, no. 15, pages 2555 - 2557
DESCRIPTION- P. E. NIELSEN; M. EGHOLM; R. H. BERG; O. BUCHARDT, SCIENCE, (1991), vol. 254, page 1497
DESCRIPTION- PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, page 5873
DESCRIPTION- ROBERTS, RG. ET AL., GENOMICS, (1993), vol. 16, pages 536 - 538
DESCRIPTION- SAMBROOK; RUSSELL, Molecular Cloning: A Laboratory Manual, COLD SPRING HARBOR, LABORATORY PRESS, (2001), vol. 3
DESCRIPTION- T. KOCH; H. F. HANSEN; P. ANDERSEN; T. LARSEN; H. G. BATZ; K. OTTESON; H. ORUM, J. PEPT. RES., (1997), vol. 49, page 80
DESCRIPTION- WILTON S. D., MOLECULAR THERAPY, (2007), vol. 15, pages 1288 - 1296
DESCRIPTION- WRIGHT ET AL., TETRAHEDRON LETTERS, (1993), vol. 34, page 3373
OPPOSITION- Popplewell, L.J. ; Adkin, C. ; Arechavala-Gomeza, V. ; Aartsma-Rus, A. ; de Winter, C.L. ; Wilton, S.D. ; Morgan, J.E. ; Muntoni, F. ; Graham, I.R. ; Dickson, G., "Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials", Neuromuscular Disorders, Elsevier Ltd, GB, GB, (20100201), vol. 20, no. 2, ISSN 0960-8966, pages 102 - 110, XP026878306
OPPOSITION- Popplewell, L.J. ; Adkin, C. ; Arechavala-Gomeza, V. ; Aartsma-Rus, A. ; de Winter, C.L. ; Wilton, S.D. ; Morgan, J.E. ; Muntoni, F. ; Graham, I.R. ; Dickson, G., "Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials", Neuromuscular Disorders, GB, (20100201), vol. 20, no. 2, ISSN 0960-8966, pages 102 - 110, XP026878306
OPPOSITION- POPPLEWELL LINDA J, ET AL, "Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD gene.", Molecular therapy, Cell Press, US, US, (20090301), vol. 17, no. 3, doi:10.1038/mt.2008.287, ISSN 1525-0016, pages 554 - 561, XP002573471
OPPOSITION- A. AARTSMA-RUS et al., "Functional Analysis of 114 Exon-Internal AONs for Targeted DMD Exon Skipping: Indication for Steric Hindrance of SR Protein Binding Sites", Oligonucleotides, (20050000), vol. 15, no. 4, doi:10.1089/oli.2005.15.284, pages 284 - 297, XP008157884
SEARCH- POPPLEWELL L J ET AL, "Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials", NEUROMUSCULAR DISORDERS, PERGAMON PRESS, GB, vol. 20, no. 2, ISSN 0960-8966, (20100201), pages 102 - 110, (20100115), XP026878306 [I] 1-4 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents